0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Plasma Fractionation Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-37Y9355
Home | Market Reports | Health| Medical Devices & Equipment
Global Blood Plasma Fractionation Market Insights and Forecast to 2028
BUY CHAPTERS

Global Blood Plasma Fractionation Market Research Report 2024

Code: QYRE-Auto-37Y9355
Report
February 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Plasma Fractionation Market Size

The global Blood Plasma Fractionation market was valued at US$ 28320 million in 2023 and is anticipated to reach US$ 47160 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.

Blood Plasma Fractionation Market

Blood Plasma Fractionation Market

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.
In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation.

Report Scope

The Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Fractionation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Blood Plasma Fractionation Market Report

Report Metric Details
Report Name Blood Plasma Fractionation Market
Accounted market size in 2023 US$ 28320 million
Forecasted market size in 2030 US$ 47160 million
CAGR 7.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Plasma Fractionation Market growing?

Ans: The Blood Plasma Fractionation Market witnessing a CAGR of 7.6% during the forecast period 2024-2030.

What is the Blood Plasma Fractionation Market size in 2030?

Ans: The Blood Plasma Fractionation Market size in 2030 will be US$ 47160 million.

What is the market share of major companies in Blood Plasma Fractionation Market?

Ans: The top 3 companies hold a share about 55%.

What is the Blood Plasma Fractionation Market share by region?

Ans: North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.

What is the Blood Plasma Fractionation Market share by type?

Ans: In terms of product, Immune Globulin is the largest segment with a share about 50%.

What is the Blood Plasma Fractionation Market share by application?

Ans: And in terms of applications, the largest application is hospital with a share about 70%.

Who are the main players in the Blood Plasma Fractionation Market report?

Ans: The main players in the Blood Plasma Fractionation Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Blood Plasma Fractionation Market report?

Ans: The Applications covered in the Blood Plasma Fractionation Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Blood Plasma Fractionation Market report?

Ans: The Types covered in the Blood Plasma Fractionation Market report are Immune Globulin, Coagulation Factor, Albumin, Other

1 Blood Plasma Fractionation Market Overview
1.1 Product Overview and Scope of Blood Plasma Fractionation
1.2 Blood Plasma Fractionation Segment by Type
1.2.1 Global Blood Plasma Fractionation Market Value Comparison by Type (2024-2030)
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Blood Plasma Fractionation Segment by Application
1.3.1 Global Blood Plasma Fractionation Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Blood Plasma Fractionation Market Size Estimates and Forecasts
1.4.1 Global Blood Plasma Fractionation Revenue 2019-2030
1.4.2 Global Blood Plasma Fractionation Sales 2019-2030
1.4.3 Global Blood Plasma Fractionation Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Blood Plasma Fractionation Market Competition by Manufacturers
2.1 Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2019-2024)
2.2 Global Blood Plasma Fractionation Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Blood Plasma Fractionation Average Price by Manufacturers (2019-2024)
2.4 Global Blood Plasma Fractionation Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Plasma Fractionation, Product Type & Application
2.7 Blood Plasma Fractionation Market Competitive Situation and Trends
2.7.1 Blood Plasma Fractionation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blood Plasma Fractionation Players Market Share by Revenue
2.7.3 Global Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Plasma Fractionation Retrospective Market Scenario by Region
3.1 Global Blood Plasma Fractionation Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Blood Plasma Fractionation Global Blood Plasma Fractionation Sales by Region: 2019-2030
3.2.1 Global Blood Plasma Fractionation Sales by Region: 2019-2024
3.2.2 Global Blood Plasma Fractionation Sales by Region: 2025-2030
3.3 Global Blood Plasma Fractionation Global Blood Plasma Fractionation Revenue by Region: 2019-2030
3.3.1 Global Blood Plasma Fractionation Revenue by Region: 2019-2024
3.3.2 Global Blood Plasma Fractionation Revenue by Region: 2025-2030
3.4 North America Blood Plasma Fractionation Market Facts & Figures by Country
3.4.1 North America Blood Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Blood Plasma Fractionation Sales by Country (2019-2030)
3.4.3 North America Blood Plasma Fractionation Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Plasma Fractionation Market Facts & Figures by Country
3.5.1 Europe Blood Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Blood Plasma Fractionation Sales by Country (2019-2030)
3.5.3 Europe Blood Plasma Fractionation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Country
3.6.1 Asia Pacific Blood Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Blood Plasma Fractionation Sales by Country (2019-2030)
3.6.3 Asia Pacific Blood Plasma Fractionation Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blood Plasma Fractionation Market Facts & Figures by Country
3.7.1 Latin America Blood Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Blood Plasma Fractionation Sales by Country (2019-2030)
3.7.3 Latin America Blood Plasma Fractionation Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Plasma Fractionation Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Blood Plasma Fractionation Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Plasma Fractionation Sales by Type (2019-2030)
4.1.1 Global Blood Plasma Fractionation Sales by Type (2019-2024)
4.1.2 Global Blood Plasma Fractionation Sales by Type (2025-2030)
4.1.3 Global Blood Plasma Fractionation Sales Market Share by Type (2019-2030)
4.2 Global Blood Plasma Fractionation Revenue by Type (2019-2030)
4.2.1 Global Blood Plasma Fractionation Revenue by Type (2019-2024)
4.2.2 Global Blood Plasma Fractionation Revenue by Type (2025-2030)
4.2.3 Global Blood Plasma Fractionation Revenue Market Share by Type (2019-2030)
4.3 Global Blood Plasma Fractionation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Blood Plasma Fractionation Sales by Application (2019-2030)
5.1.1 Global Blood Plasma Fractionation Sales by Application (2019-2024)
5.1.2 Global Blood Plasma Fractionation Sales by Application (2025-2030)
5.1.3 Global Blood Plasma Fractionation Sales Market Share by Application (2019-2030)
5.2 Global Blood Plasma Fractionation Revenue by Application (2019-2030)
5.2.1 Global Blood Plasma Fractionation Revenue by Application (2019-2024)
5.2.2 Global Blood Plasma Fractionation Revenue by Application (2025-2030)
5.2.3 Global Blood Plasma Fractionation Revenue Market Share by Application (2019-2030)
5.3 Global Blood Plasma Fractionation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Blood Plasma Fractionation Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Blood Plasma Fractionation Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Blood Plasma Fractionation Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Corporation Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotest Blood Plasma Fractionation Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Corporation Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BPL Blood Plasma Fractionation Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Corporation Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 RAAS Blood Plasma Fractionation Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Blood Plasma Fractionation Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Blood Plasma Fractionation Description and Business Overview
6.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Tiantan Bio
6.12.1 Tiantan Bio Corporation Information
6.12.2 Tiantan Bio Blood Plasma Fractionation Description and Business Overview
6.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
6.12.5 Tiantan Bio Recent Developments/Updates
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Corporation Information
6.13.2 Shuanglin Bio Blood Plasma Fractionation Description and Business Overview
6.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
6.13.5 Shuanglin Bio Recent Developments/Updates
6.14 Boya Bio
6.14.1 Boya Bio Corporation Information
6.14.2 Boya Bio Blood Plasma Fractionation Description and Business Overview
6.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
6.14.5 Boya Bio Recent Developments/Updates
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Corporation Information
6.15.2 Yuanda Shuyang Blood Plasma Fractionation Description and Business Overview
6.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments/Updates
6.16 Weiguang Bio
6.16.1 Weiguang Bio Corporation Information
6.16.2 Weiguang Bio Blood Plasma Fractionation Description and Business Overview
6.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
6.16.5 Weiguang Bio Recent Developments/Updates
6.17 Nanyue Bio
6.17.1 Nanyue Bio Corporation Information
6.17.2 Nanyue Bio Blood Plasma Fractionation Description and Business Overview
6.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
6.17.5 Nanyue Bio Recent Developments/Updates
6.18 KM Biologics
6.18.1 KM Biologics Corporation Information
6.18.2 KM Biologics Blood Plasma Fractionation Description and Business Overview
6.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2024)
6.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
6.18.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Plasma Fractionation Industry Chain Analysis
7.2 Blood Plasma Fractionation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Plasma Fractionation Production Mode & Process
7.4 Blood Plasma Fractionation Sales and Marketing
7.4.1 Blood Plasma Fractionation Sales Channels
7.4.2 Blood Plasma Fractionation Distributors
7.5 Blood Plasma Fractionation Customers
8 Blood Plasma Fractionation Market Dynamics
8.1 Blood Plasma Fractionation Industry Trends
8.2 Blood Plasma Fractionation Market Drivers
8.3 Blood Plasma Fractionation Market Challenges
8.4 Blood Plasma Fractionation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Blood Plasma Fractionation Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Blood Plasma Fractionation Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Blood Plasma Fractionation Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Blood Plasma Fractionation Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Blood Plasma Fractionation Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Blood Plasma Fractionation Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Blood Plasma Fractionation Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Blood Plasma Fractionation, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Blood Plasma Fractionation, Product Type & Application
    Table 12. Global Key Manufacturers of Blood Plasma Fractionation, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Blood Plasma Fractionation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Blood Plasma Fractionation Sales by Region (2019-2024) & (K Units)
    Table 18. Global Blood Plasma Fractionation Sales Market Share by Region (2019-2024)
    Table 19. Global Blood Plasma Fractionation Sales by Region (2025-2030) & (K Units)
    Table 20. Global Blood Plasma Fractionation Sales Market Share by Region (2025-2030)
    Table 21. Global Blood Plasma Fractionation Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Blood Plasma Fractionation Revenue Market Share by Region (2019-2024)
    Table 23. Global Blood Plasma Fractionation Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Blood Plasma Fractionation Revenue Market Share by Region (2025-2030)
    Table 25. North America Blood Plasma Fractionation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
    Table 27. North America Blood Plasma Fractionation Sales by Country (2025-2030) & (K Units)
    Table 28. North America Blood Plasma Fractionation Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Blood Plasma Fractionation Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Blood Plasma Fractionation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Blood Plasma Fractionation Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Blood Plasma Fractionation Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Blood Plasma Fractionation Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Blood Plasma Fractionation Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Blood Plasma Fractionation Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Blood Plasma Fractionation Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Blood Plasma Fractionation Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Blood Plasma Fractionation Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Blood Plasma Fractionation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Blood Plasma Fractionation Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Blood Plasma Fractionation Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Blood Plasma Fractionation Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Blood Plasma Fractionation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Blood Plasma Fractionation Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Blood Plasma Fractionation Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Blood Plasma Fractionation Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Blood Plasma Fractionation Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Blood Plasma Fractionation Sales (K Units) by Type (2019-2024)
    Table 51. Global Blood Plasma Fractionation Sales (K Units) by Type (2025-2030)
    Table 52. Global Blood Plasma Fractionation Sales Market Share by Type (2019-2024)
    Table 53. Global Blood Plasma Fractionation Sales Market Share by Type (2025-2030)
    Table 54. Global Blood Plasma Fractionation Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Blood Plasma Fractionation Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Blood Plasma Fractionation Revenue Market Share by Type (2019-2024)
    Table 57. Global Blood Plasma Fractionation Revenue Market Share by Type (2025-2030)
    Table 58. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Blood Plasma Fractionation Sales (K Units) by Application (2019-2024)
    Table 61. Global Blood Plasma Fractionation Sales (K Units) by Application (2025-2030)
    Table 62. Global Blood Plasma Fractionation Sales Market Share by Application (2019-2024)
    Table 63. Global Blood Plasma Fractionation Sales Market Share by Application (2025-2030)
    Table 64. Global Blood Plasma Fractionation Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Blood Plasma Fractionation Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Blood Plasma Fractionation Revenue Market Share by Application (2019-2024)
    Table 67. Global Blood Plasma Fractionation Revenue Market Share by Application (2025-2030)
    Table 68. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2025-2030)
    Table 70. Takeda Corporation Information
    Table 71. Takeda Description and Business Overview
    Table 72. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Takeda Blood Plasma Fractionation Product
    Table 74. Takeda Recent Developments/Updates
    Table 75. CSL Corporation Information
    Table 76. CSL Description and Business Overview
    Table 77. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. CSL Blood Plasma Fractionation Product
    Table 79. CSL Recent Developments/Updates
    Table 80. Grifols Corporation Information
    Table 81. Grifols Description and Business Overview
    Table 82. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Grifols Blood Plasma Fractionation Product
    Table 84. Grifols Recent Developments/Updates
    Table 85. Octapharma Corporation Information
    Table 86. Octapharma Description and Business Overview
    Table 87. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Octapharma Blood Plasma Fractionation Product
    Table 89. Octapharma Recent Developments/Updates
    Table 90. Kedrion Corporation Information
    Table 91. Kedrion Description and Business Overview
    Table 92. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Kedrion Blood Plasma Fractionation Product
    Table 94. Kedrion Recent Developments/Updates
    Table 95. LFB Group Corporation Information
    Table 96. LFB Group Description and Business Overview
    Table 97. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. LFB Group Blood Plasma Fractionation Product
    Table 99. LFB Group Recent Developments/Updates
    Table 100. Biotest Corporation Information
    Table 101. Biotest Description and Business Overview
    Table 102. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Biotest Blood Plasma Fractionation Product
    Table 104. Biotest Recent Developments/Updates
    Table 105. BPL Corporation Information
    Table 106. BPL Description and Business Overview
    Table 107. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. BPL Blood Plasma Fractionation Product
    Table 109. BPL Recent Developments/Updates
    Table 110. RAAS Corporation Information
    Table 111. RAAS Description and Business Overview
    Table 112. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. RAAS Blood Plasma Fractionation Product
    Table 114. RAAS Recent Developments/Updates
    Table 115. CBPO Corporation Information
    Table 116. CBPO Description and Business Overview
    Table 117. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. CBPO Blood Plasma Fractionation Product
    Table 119. CBPO Recent Developments/Updates
    Table 120. Hualan Bio Corporation Information
    Table 121. Hualan Bio Description and Business Overview
    Table 122. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Hualan Bio Blood Plasma Fractionation Product
    Table 124. Hualan Bio Recent Developments/Updates
    Table 125. Tiantan Bio Corporation Information
    Table 126. Tiantan Bio Description and Business Overview
    Table 127. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Tiantan Bio Blood Plasma Fractionation Product
    Table 129. Tiantan Bio Recent Developments/Updates
    Table 130. Shuanglin Bio Corporation Information
    Table 131. Shuanglin Bio Description and Business Overview
    Table 132. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Shuanglin Bio Blood Plasma Fractionation Product
    Table 134. Shuanglin Bio Recent Developments/Updates
    Table 135. Boya Bio Corporation Information
    Table 136. Boya Bio Description and Business Overview
    Table 137. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Boya Bio Blood Plasma Fractionation Product
    Table 139. Boya Bio Recent Developments/Updates
    Table 140. Yuanda Shuyang Corporation Information
    Table 141. Yuanda Shuyang Description and Business Overview
    Table 142. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Yuanda Shuyang Blood Plasma Fractionation Product
    Table 144. Yuanda Shuyang Recent Developments/Updates
    Table 145. Weiguang Bio Corporation Information
    Table 146. Weiguang Bio Description and Business Overview
    Table 147. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Weiguang Bio Blood Plasma Fractionation Product
    Table 149. Weiguang Bio Recent Developments/Updates
    Table 150. Nanyue Bio Corporation Information
    Table 151. Nanyue Bio Description and Business Overview
    Table 152. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Nanyue Bio Blood Plasma Fractionation Product
    Table 154. Nanyue Bio Recent Developments/Updates
    Table 155. KM Biologics Corporation Information
    Table 156. KM Biologics Description and Business Overview
    Table 157. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 158. KM Biologics Blood Plasma Fractionation Product
    Table 159. KM Biologics Recent Developments/Updates
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Blood Plasma Fractionation Distributors List
    Table 163. Blood Plasma Fractionation Customers List
    Table 164. Blood Plasma Fractionation Market Trends
    Table 165. Blood Plasma Fractionation Market Drivers
    Table 166. Blood Plasma Fractionation Market Challenges
    Table 167. Blood Plasma Fractionation Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Blood Plasma Fractionation
    Figure 2. Global Blood Plasma Fractionation Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Blood Plasma Fractionation Market Share by Type in 2023 & 2030
    Figure 4. Immune Globulin Product Picture
    Figure 5. Coagulation Factor Product Picture
    Figure 6. Albumin Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Blood Plasma Fractionation Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Blood Plasma Fractionation Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Retail Pharmacy
    Figure 12. Other
    Figure 13. Global Blood Plasma Fractionation Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Blood Plasma Fractionation Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Blood Plasma Fractionation Sales (2019-2030) & (K Units)
    Figure 16. Global Blood Plasma Fractionation Average Price (US$/Unit) & (2019-2030)
    Figure 17. Blood Plasma Fractionation Report Years Considered
    Figure 18. Blood Plasma Fractionation Sales Share by Manufacturers in 2023
    Figure 19. Global Blood Plasma Fractionation Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Blood Plasma Fractionation Players: Market Share by Revenue in 2023
    Figure 21. Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Blood Plasma Fractionation Sales Market Share by Country (2019-2030)
    Figure 24. North America Blood Plasma Fractionation Revenue Market Share by Country (2019-2030)
    Figure 25. United States Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Blood Plasma Fractionation Sales Market Share by Country (2019-2030)
    Figure 28. Europe Blood Plasma Fractionation Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Blood Plasma Fractionation Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Blood Plasma Fractionation Revenue Market Share by Region (2019-2030)
    Figure 36. China Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Blood Plasma Fractionation Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Blood Plasma Fractionation Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Blood Plasma Fractionation Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Blood Plasma Fractionation Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Blood Plasma Fractionation Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Blood Plasma Fractionation by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Blood Plasma Fractionation by Type (2019-2030)
    Figure 57. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Blood Plasma Fractionation by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Blood Plasma Fractionation by Application (2019-2030)
    Figure 60. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2019-2030)
    Figure 61. Blood Plasma Fractionation Value Chain
    Figure 62. Blood Plasma Fractionation Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global PET Scan Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4Z8672
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Cell Expansion Disposable Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14V8437
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Microtest Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32R8350
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Tissue Slicer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26U3291
Wed Apr 17 00:00:00 UTC 2024

Add to Cart